TrialPloS one2022

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.

Charlotte C Hamel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.